大小可以预测侵略性吗? : 探索零星多焦点瘤在10年的回顾分析
Felicia L Pasadyn1, Dongling Wu2, Shavy Nagpal3
1Department of Urology, NYU Langone Health, New York, NY.
Clinical genitourinary cancer
|July 11, 2025
概括
多焦点脏瘤通常具有不同的癌症类型. 仅仅依赖于最大的瘤.
科学领域:
- 尿道瘤学 尿道瘤学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 手术病理学手术病理学
背景情况:
- 局部瘤的恶性潜力通常是由大小和生长预测的.
- 多焦点质的治疗通常优先考虑最大或指数瘤.
- 零星多焦点瘤的侵袭性需要进一步调查.
研究的目的:
- 为了检查零星多焦点脏瘤的组织学一致性.
- 确定瘤大小是否是多焦点脏瘤攻击性的主要决定因素.
主要方法:
- 对128名患有零星多焦点瘤的脏瘤患者进行脏切除术的回顾性图表审查.
- 分析外科病理参数,包括瘤大小,TNM分级和分期.
- 排除患有综合征性疾病的患者.
主要成果:
- 64%的多焦点脏瘤表现出一致的组织学;36%是不一致的.
- 索引瘤在77.3%的患者中显示出更具攻击性的组织学.
- 16%的良性指数瘤患者患有恶性二次瘤.
结论:
- 多焦点脏瘤经常出现与异调的组织学.
- 瘤大小并不总是侵略性的最大决定因素.
- 管理零星多焦点细胞癌 (RCC) 需要考虑非指数病变,因为有可能更具侵略性的疾病.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
372
03:41High-Resolution Ultrasonography for the Analysis of Orthotopic ATC Tumors in a Genetically Engineered Mouse Model
Published on: October 11, 2022
1.9K
相关概念视频
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
